We just received data on a new analyst forecast for $INSM. Andrew S. Fein from HC Wainwright & Co. set a price target of 230.0 for INSM.
To track analyst ratings and price targets for $INSM, check out Quiver Quantitative's $INSM forecast page.
Should you buy $INSM?
Some analysts are better than others. To view the past performance of HC Wainwright & Co., check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$INSM Price Targets
Multiple analysts have issued price targets for $INSM recently. We have seen 15 analysts offer price targets for $INSM in the last 6 months, with a median target of $221.0.
Here are some recent targets:
- Andrew S. Fein from HC Wainwright & Co. set a target price of $230.0 on 02/23/2026
- Benjamin Burnett from Wells Fargo set a target price of $208.0 on 02/20/2026
- Matthew Harrison from Morgan Stanley set a target price of $162.0 on 01/30/2026
- Eliana Merle from Barclays set a target price of $231.0 on 01/28/2026
- Adam Walsh from Roth Capital set a target price of $212.0 on 01/23/2026
- Leonid Timashev from RBC Capital set a target price of $200.0 on 01/21/2026
- Ashwani Verma from UBS set a target price of $215.0 on 01/06/2026
$INSM Insider Trading Activity
$INSM insiders have traded $INSM stock on the open market 111 times in the past 6 months. Of those trades, 0 have been purchases and 111 have been sales.
Here’s a breakdown of recent trading of $INSM stock by insiders over the last 6 months:
- MARTINA M.D. FLAMMER (Chief Medical Officer) has made 0 purchases and 35 sales selling 267,135 shares for an estimated $41,532,420.
- ORLOV S NICOLE SCHAEFFER (Chief People Strategy Officer) has made 0 purchases and 8 sales selling 106,520 shares for an estimated $16,949,988.
- LEO LEE has made 0 purchases and 5 sales selling 75,000 shares for an estimated $14,692,249.
- WILLIAM LEWIS (Chair and CEO) has made 0 purchases and 33 sales selling 77,393 shares for an estimated $13,068,271.
- MICHAEL ALEXANDER SMITH (Chief Legal Officer) has made 0 purchases and 18 sales selling 55,200 shares for an estimated $9,127,795.
- MELVIN MD SHAROKY has made 0 purchases and 2 sales selling 30,000 shares for an estimated $5,554,100.
- ELIZABETH M ANDERSON has made 0 purchases and 2 sales selling 15,000 shares for an estimated $2,981,600.
- SARA BONSTEIN (Chief Financial Officer) has made 0 purchases and 4 sales selling 5,390 shares for an estimated $925,675.
- ROGER ADSETT (Chief Operating Officer) has made 0 purchases and 4 sales selling 5,081 shares for an estimated $870,241.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$INSM Congressional Stock Trading
Members of Congress have traded $INSM stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $INSM stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/03, 09/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$INSM Hedge Fund Activity
We have seen 406 institutional investors add shares of $INSM stock to their portfolio, and 320 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,892,000 shares (-41.7%) from their portfolio in Q4 2025, for an estimated $503,323,680
- BLACKROCK, INC. added 2,700,148 shares (+21.8%) to their portfolio in Q4 2025, for an estimated $469,933,757
- CAPITAL INTERNATIONAL INVESTORS removed 2,402,182 shares (-31.8%) from their portfolio in Q4 2025, for an estimated $418,075,755
- RTW INVESTMENTS, LP added 1,758,321 shares (+57.0%) to their portfolio in Q4 2025, for an estimated $306,018,186
- DEEP TRACK CAPITAL, LP removed 1,750,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $252,017,499
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,606,949 shares (-56.2%) from their portfolio in Q3 2025, for an estimated $231,416,725
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,544,315 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $268,772,582
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
